Cholangiocarcinoma: molecular pathways and therapeutic opportunities

Area of Science:

• Oncology
• Gastroenterology
• Molecular Biology

Background:

• Cholangiocarcinoma (CCA) is an aggressive biliary tract cancer with poor prognosis and limited therapeutic options.
• Current treatments for CCA are insufficient, highlighting the need for novel therapeutic strategies.

Purpose of the Study:

• To review recent advances in understanding the genetic basis of CCA.
• To identify therapeutically relevant molecular targets and pathways for CCA treatment.
• To discuss the role of the tumor microenvironment, specifically the desmoplastic stroma, in CCA progression and treatment.

Main Methods:

• Review of recent scientific literature on CCA genetics, molecular pathways, and therapeutic targets.
• Analysis of emerging treatment strategies targeting specific genetic aberrations and the tumor stroma.
• Discussion of the potential of molecular profiling for personalized medicine in CCA.

Main Results:

• Key therapeutic targets include receptor tyrosine kinase pathways, mutant IDH enzymes, the PI3K-AKT-mTOR pathway, and chromatin remodeling networks.
• Targeting the desmoplastic stroma through stromal myofibroblast depletion is a promising approach.
• Combination therapies targeting both cancer cells and the tumor stroma are likely to be most effective.

Conclusions:

• Advances in understanding CCA's genetic landscape are paving the way for targeted therapies.
• Personalized treatment strategies based on molecular profiling hold significant promise for improving patient outcomes.
• Future research should focus on developing combination therapies that address both cancer cell-intrinsic pathways and the tumor microenvironment.